HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Kramer Selected Research

Hydroxyethylrutoside

4/20007-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Kramer Research Topics

Disease

12Neuroblastoma
05/2013 - 03/2000
11Neoplasms (Cancer)
11/2016 - 03/2000
2Cardiotoxicity
05/2001 - 04/2000
1Hypophosphatasia
01/2021
1Breast Neoplasms (Breast Cancer)
11/2016
1Anastomotic Leak
06/2013
1Hyponatremia
05/2013
1Lymphangioma (Cavernous Lymphangioma)
07/2010
1Rectal Neoplasms (Rectal Cancer)
12/2009
1Dyspnea (Shortness of Breath)
09/2009
1Stroke (Strokes)
02/2009
1Aphasia (Dysphasia)
02/2009
1Dermatitis
08/2008
1Pulmonary Hypertension
02/2008
1Pulmonary Embolism
02/2008
1Poisoning
12/2007
1Ketosis
12/2007
1Acidosis
12/2007
1Gastrointestinal Hemorrhage (Hematochezia)
03/2005
1Necrosis
07/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2002
1Diverticulitis
01/2002
1Ulcerative Colitis
01/2002
1Brain Neoplasms (Brain Tumor)
09/2001
1Body Weight (Weight, Body)
07/2001
1Pain (Aches)
01/2001
1Urticaria (Hives)
01/2001
1Mucositis
01/2001
1Thrombocytopenia (Thrombopenia)
11/2000
1Neutropenia
11/2000
1Mycoses (Diseases, Fungus)
11/2000
1Infections
11/2000
1Heart Failure
04/2000

Drug/Important Bio-Agent (IBA)

4Monoclonal AntibodiesIBA
11/2001 - 01/2001
3Topotecan (Hycamtin)FDA LinkGeneric
02/2006 - 11/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2001 - 04/2000
2Carboplatin (JM8)FDA LinkGeneric
02/2006 - 09/2001
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
02/2006 - 09/2001
2Alkylating AgentsIBA
09/2001 - 11/2000
2Immunoglobulin G (IgG)IBA
05/2001 - 12/2000
27-monohydroxyethylrutosideIBA
05/2001 - 04/2000
2FlavonoidsIBA
05/2001 - 04/2000
2Vincristine (Oncovin)FDA LinkGeneric
01/2001 - 11/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2000 - 11/2000
1N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
01/2021
1Angiogenesis InhibitorsIBA
11/2016
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
11/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2016
1Phenobarbital (Luminal)FDA Link
11/2016
1Sunitinib (Sutent)FDA Link
11/2016
1EnzymesIBA
05/2013
1von Willebrand FactorIBA
07/2010
1VimentinIBA
07/2010
1BaclofenFDA LinkGeneric
09/2009
1GlucocorticoidsIBA
08/2008
1MonocrotalineIBA
02/2008
11-Propanol (Propanol)IBA
12/2007
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
12/2007
1propionic acid (potassium propionate)IBA
12/2007
12-Propanol (Isopropyl Alcohol)FDA LinkGeneric
12/2007
1AcetoneIBA
12/2007
1Hemoglobins (Hemoglobin)IBA
03/2005
1Acetaminophen (Paracetamol)FDA LinkGeneric
07/2002
1Biomarkers (Surrogate Marker)IBA
07/2002
1Alanine Transaminase (SGPT)IBA
07/2002
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2001
1CytokinesIBA
10/2001
1Fluorine-18IBA
07/2001
1Vasopressins (Vasopressin)IBA
07/2001
1methylhistaprodifenIBA
07/2001
1Surface Antigens (Surface Antigen)IBA
05/2001
1AntigensIBA
05/2001
18H9 monoclonal antibodyIBA
05/2001
1frederineIBA
05/2001
1Cisplatin (Platino)FDA LinkGeneric
11/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2000
1Etoposide (VP 16)FDA LinkGeneric
11/2000
1trioctyl phosphine oxide (TOPO)IBA
11/2000
1Antineoplastic Agents (Antineoplastics)IBA
04/2000
1HydroxyethylrutosideIBA
04/2000

Therapy/Procedure

11Therapeutics
11/2016 - 03/2000
5Drug Therapy (Chemotherapy)
11/2016 - 03/2000
4Radiotherapy
09/2001 - 03/2000
2Chemoradiotherapy
06/2013 - 12/2009
2Radioimmunotherapy
01/2001 - 12/2000
1Neoadjuvant Therapy
12/2009
1General Anesthesia
09/2009
1Language Therapy (Language Training)
02/2009
1Immunotherapy
01/2001
1CVACE protocol
01/2001
1Combination Drug Therapy (Combination Chemotherapy)
11/2000